AstraZeneca PLC banner

AstraZeneca PLC
LSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
LSE:AZN
Watchlist
Price: 12 540 GBX -0.1%
Market Cap: £194.5B

Wall St Price Targets

AZN Price Forecast
Based on 30 analysts

+30% Upside
from 12 540 GBX today

AstraZeneca PLC (AZN)’s 12-month stock price forecast through September 2027 has a consensus target of 16 320 GBX, implying 30% upside. The forecast is based on price targets from 30 Wall Street analysts.

AZN Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for AZN yet.

AstraZeneca PLC Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AZN's stock price target?
Price Target
16 320 GBX

According to Wall Street analysts, the average 1-year price target for AZN is 16 320 GBX with a low forecast of 6 678.56 GBX and a high forecast of 21 210 GBX.

What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 6%.

What is the Gross Profit forecast for AstraZeneca PLC?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 6%.

What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 13%.

What is the Pre-Tax Income forecast for AstraZeneca PLC?
Projected CAGR
25%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 25%.

What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 13%.

Back to Top